HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Kuwano Selected Research

bastadin 6

3/2006Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Kuwano Research Topics

Disease

14Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 01/2011
9Hypertension (High Blood Pressure)
09/2023 - 01/2011
7Cardiovascular Diseases (Cardiovascular Disease)
02/2021 - 01/2011
6Heart Failure
01/2023 - 01/2016
6Neoplasms (Cancer)
07/2012 - 05/2002
5Myocardial Infarction
10/2021 - 03/2011
4Diabetes Mellitus
10/2021 - 01/2011
4Body Weight (Weight, Body)
04/2021 - 01/2015
4Dyslipidemias (Dyslipidemia)
02/2021 - 10/2019
3Ischemic Stroke
10/2021 - 10/2020
3Atherosclerosis
02/2021 - 10/2014
3Thrombosis (Thrombus)
03/2017 - 03/2011
2Coronary Stenosis (Coronary Artery Stenosis)
04/2024 - 11/2020
2Inflammation (Inflammations)
03/2023 - 11/2020
2Myocardial Ischemia (Ischemic Heart Diseases)
04/2021 - 01/2016
2Reperfusion Injury
04/2021 - 01/2016
2Fibrosis (Cirrhosis)
07/2019 - 01/2016
2Stable Angina
02/2018 - 08/2016
2Neoplasm Metastasis (Metastasis)
01/2006 - 11/2005
1Left Ventricular Dysfunction
01/2023
1Obesity
11/2021
1Hyperemia
02/2021
1Arteriosclerosis Obliterans
02/2021
1Cardiomegaly (Heart Hypertrophy)
12/2020
1Hypertrophy
12/2020
1Atherosclerotic Plaque (Atheroma)
10/2020
1Glioblastoma (Glioblastoma Multiforme)
12/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019
1Coronary Disease (Coronary Heart Disease)
10/2019
1Insulin Resistance
03/2018
1Acute Coronary Syndrome
02/2018
1Dementia (Dementias)
12/2017
1Essential Hypertension
05/2017
1Type 2 Diabetes Mellitus (MODY)
03/2017
1Pathologic Constriction (Stenosis)
01/2017

Drug/Important Bio-Agent (IBA)

6omega-Chloroacetophenone (Mace)IBA
09/2023 - 01/2011
6LipidsIBA
02/2021 - 01/2017
6CholesterolIBA
12/2019 - 10/2014
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024 - 04/2018
4oxidized low density lipoproteinIBA
04/2024 - 02/2018
4Angiotensin IIIBA
12/2020 - 11/2016
4Hydrochlorothiazide (Esidrix)FDA LinkGeneric
02/2017 - 01/2011
3HDL CholesterolIBA
02/2021 - 11/2020
3sacubitril and valsartan sodium hydrate drug combinationIBA
12/2020 - 01/2016
3Neprilysin (Neutral Endopeptidase)IBA
12/2020 - 01/2016
3Valsartan (Vals)FDA Link
12/2020 - 01/2011
3HDL LipoproteinsIBA
03/2017 - 01/2016
3AnticoagulantsIBA
03/2017 - 01/2016
3Losartan (Cozaar)FDA LinkGeneric
12/2015 - 01/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2012 - 05/2002
2Blood Glucose (Blood Sugar)IBA
04/2021 - 02/2021
2MetalsIBA
02/2021 - 08/2016
2Triglycerides (Triacylglycerol)IBA
02/2021 - 10/2018
2LDL CholesterolIBA
02/2021 - 08/2016
2EnalaprilFDA LinkGeneric
12/2020 - 11/2016
2Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2020 - 01/2016
2Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2019
2Ezetimibe (Zetia)FDA Link
11/2020 - 10/2019
2Complementary DNA (cDNA)IBA
12/2019 - 01/2006
2Angiotensin Receptor AntagonistsIBA
05/2017 - 10/2016
2Vitamin KFDA Link
03/2017 - 12/2016
2Angiotensin II Type 1 Receptor BlockersIBA
02/2017 - 09/2012
2Peptides (Polypeptides)IBA
01/2016 - 07/2012
1C-Reactive ProteinIBA
03/2023
1LinagliptinIBA
04/2021
1empagliflozinIBA
04/2021
1Hemoglobins (Hemoglobin)IBA
02/2021
1UbiquitinIBA
11/2020
1high density lipoprotein binding proteinIBA
11/2020
1AngiopoietinsIBA
11/2020
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2020
1Platelet Activating FactorIBA
10/2019
1SubtilisinIBA
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019
1Coloring Agents (Dyes)IBA
04/2018
1von Willebrand FactorIBA
04/2018
1Uric Acid (Urate)IBA
03/2018
1EnzymesIBA
03/2018
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2017
1Biomarkers (Surrogate Marker)IBA
12/2017
1azilsartanIBA
05/2017
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2017
1TolvaptanFDA Link
05/2017
1olmesartanIBA
05/2017
1N(6)-carboxymethyllysine (carboxymethyllysine)IBA
03/2017
1AldosteroneIBA
03/2017
1Thiobarbituric Acid Reactive SubstancesIBA
03/2017
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
02/2017
1apixabanIBA
12/2016
1RivaroxabanIBA
12/2016

Therapy/Procedure

7Therapeutics
04/2021 - 07/2012
4Stents
02/2021 - 03/2011
3Aftercare (After-Treatment)
05/2017 - 09/2012
2Catheters
04/2021 - 01/2016
2Renal Dialysis (Hemodialysis)
02/2021 - 02/2018
2Drug-Eluting Stents
02/2021 - 08/2016
2Percutaneous Coronary Intervention
10/2020 - 08/2016
2Cardiac Rehabilitation
12/2017 - 09/2016
1Patient Readmission
01/2023
1Ambulatory Care (Outpatient Care)
10/2020